ANGLE PLC CEO Announces Breakthrough in CellKeep Technology
ANGLE PLC CEO Announces Breakthrough in CellKeep Technology
Key Takeaways (TLDR)
ANGLE PLC's CellKeep slide technology reduces cell loss by over 70%, giving labs a competitive edge in efficiency and diagnostic reliability.
The CellKeep slide involves a special funnel for gentle centrifugation and liquid removal, enhancing the effectiveness of subsequent analyses in medical laboratories.
ANGLE's CellKeep slide technology makes the diagnostic process more reliable and efficient, ultimately improving patient care and treatment outcomes.
ANGLE PLC's breakthrough in DNA profiling and substantial contract with a major pharmaceutical company opens new possibilities for companion diagnostics and medical advancements.
Why it Matters
The breakthrough in CellKeep technology and optimized antibodies for cell phenotyping will significantly impact medical laboratories, improving the reliability and efficiency of diagnostic processes. This news is important for anyone in the medical research and diagnostic industry, as it represents a major step forward in addressing longstanding issues, ultimately leading to better healthcare outcomes.
Summary
ANGLE PLC CEO Andrew Newland has announced major technological advancements, including a European patent for the CellKeep slide, with US intellectual property protection soon to follow. The CellKeep slide addresses the issue of cell loss during transfer, reducing it by over 70% and improving subsequent analyses. Additionally, ANGLE has developed optimized antibodies for cell phenotyping, integrated into the Parsortix system as the Portrait Plus CTC Staining Kit, making the diagnostic process more reliable and efficient. These innovations are now available in a comprehensive kit format, enhancing the company's value offering.
This news story relied on a press release distributed by News Direct. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is ANGLE PLC CEO Announces Breakthrough in CellKeep Technology.